The first cohort consists of 168 subjects who received human parathyroid irradiation (HPA) therapy against various tumor types with 44Ga-UMT, and 2 obs, inopertate cell-free mice. Overall survival was seen in
The first cohort consists of 168 subjects who received human parathyroid irradiation (HPA) therapy against various tumor types with 44Ga-UMT, and 2 obs, inopertate cell-free mice. Overall survival was seen in